✦ LIBER ✦

281 Efficacy of long acting release octreotide in patients with advanced hepatocellular carcinoma: A randomized multicenter phase III study

✍ Scribed by C. Verslype; G. Verset; H. Reynaert; I. Borbath; P. Langlet; A. Vandebroek; M. Peeters; G. Houbiers; P. Michielsen; M. Arvanitaki; J.L. Van Laethem

Book ID: 117374561
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 128 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80282-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of the combination of long-acti

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study

✍ Verset, G; Verslype, C; Reynaert, H; Borbath, I; Langlet, P; Vandebroek, A; Peet 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Sorafenib plus long-acting octreotide in

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

✍ S. Del Prete; R. Addeo; L. Maiorino; G. Cennamo; V. Montesarchio; L. Leo; V. Fai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Treatment of advanced hepatocellular car

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study

✍ Jean-Claude Barbare; Olivier Bouché; Franck Bonnetain; Laetitia Dahan; Catherine 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 346 KB

242 The role of long acting octreotide i

242 The role of long acting octreotide in treating patients with advanced hepatocellular cancer (HCC). A randomized placebo-controlled trial

✍ D. Dimitroulopoulos; D. Xinopoulos; K. Tsamakidis; A. Zisimopoulos; E. Andriotis 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

✍ Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 934 KB

A phase II and pharmacokinetic study of

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB